☆ 4.7 Article

Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics

Mohammad H. Alshaer et al.

Summary: In this study, a cefepime model for clinical application was developed and validated. The model was integrated in a precision dosing tool with a median concentration prediction bias of 4%. The optimal initial dose algorithm was provided.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Pharmacokinetics and Pharmacodynamics of Cefepime

Gwendolyn M. Pais et al.

Summary: Cefepime is a broad-spectrum antibiotic with activity against various bacteria. It can be administered through infusion or prolonged infusion. In healthy adults with normal renal function, cefepime is widely distributed and about 85% of the dose is excreted unchanged in the urine, with an elimination half-life of 2-2.3 hours. The pharmacokinetics of cefepime can be altered under certain pathophysiological conditions, resulting in high inter-individual variability and posing challenges for population dosing approaches. Therapeutic drug monitoring of cefepime may be beneficial in certain special patients.

CLINICAL PHARMACOKINETICS (2022)

添加到收藏夹

Article Infectious Diseases

Continuous infusion of cefepime and neurotoxicity: a retrospective cohort study

C. Vercheval et al.

Summary: This study aimed to evaluate the incidence of neurotoxicity related to continuous infusion of cefepime and its associated risk factors. Results showed that patients with neurotoxicity were more likely to have underlying brain disease and higher steady-state concentrations of cefepime. Adjusting cefepime dosage based on renal function can achieve a balance between risk and benefit.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines

Cindy Lau et al.

Summary: This study found that cefepime exposure is highly predictive of CIN, with a C-min of 49 mg/L identified as the most appropriate toxicity threshold. Evaluation showed that only 29% of patients achieved therapeutic targets with cefepime dosing regimens, with impaired renal function patients more likely to have subtherapeutic concentrations and patients with normal renal function at risk of potentially toxic exposure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

添加到收藏夹

Article Microbiology

Target-Controlled Infusion of Cefepime in Critically Ill Patients

Stijn Jonckheere et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Microbiology

Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing

Mohammad H. Al-Shaer et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Review Critical Care Medicine

Cefepime-induced neurotoxicity: a systematic review

Lauren E. Payne et al.

CRITICAL CARE (2017)

添加到收藏夹

Article Infectious Diseases

Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study

T. Huwyler et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

添加到收藏夹

Article Infectious Diseases

A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU

Stijn Jonckheere et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

添加到收藏夹

Article Infectious Diseases

Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapy

Mieke Carlier et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)

添加到收藏夹

Article Immunology

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

Jason A. Roberts et al.

CLINICAL INFECTIOUS DISEASES (2014)

添加到收藏夹

Article Microbiology

Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients

Federico Pea et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

添加到收藏夹

Article Microbiology

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

Anthony M. Nicasio et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

添加到收藏夹

Article Infectious Diseases

Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units

Juliana F. Roos et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

添加到收藏夹

Review Pharmacology & Pharmacy

Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on beta-lactam antibiotics - Insights from the society of infectious diseases pharmacists

Thomas P. Lodise et al.

PHARMACOTHERAPY (2006)

添加到收藏夹

Article Pharmacology & Pharmacy

Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides

I Matthews et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)

添加到收藏夹

Article Microbiology

Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function

VH Tam et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.